Skip to main
SNWV

SNWV Stock Forecast & Price Target

SNWV Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SANUWAVE Health Inc. demonstrated substantial financial growth in 2024, with a remarkable 60% year-over-year increase in sales, reaching $32.6 million, primarily fueled by both system sales and consumables. The company's adjusted EBITDA also showed significant improvement, rising by 28 percentage points to 22%, indicating enhanced operational efficiency and profitability. While operating expenses increased slightly due to non-cash stock-based compensation, the overall strong sales growth and positive EBITDA trends contribute to a favorable outlook for SANUWAVE Health's stock.

Bears say

The financial outlook for SANUWAVE Health reflects several challenges that could negatively impact its stock performance. First, the company's applicator usage declined modestly in the first quarter, a typical seasonal trend influenced by patient behavior and insurance deductible resets, which may hinder revenue growth. Additionally, key concerns surrounding margin compression, competitive pressures, reduced sales representative productivity, and potential manufacturing setbacks raise significant doubts about the company's ability to achieve sustainable financial performance.

SNWV has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SANUWAVE Health Inc (SNWV) Forecast

Analysts have given SNWV a Buy based on their latest research and market trends.

According to 2 analysts, SNWV has a Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SANUWAVE Health Inc (SNWV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.